Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Follicular lymphoma of the spleen: multiparameter analysis of 16 cases.

Howard MT, Dufresne S, Swerdlow SH, Cook JR.

Am J Clin Pathol. 2009 May;131(5):656-62. doi: 10.1309/AJCPF9V8XRDYWTIR.

PMID:
19369624
2.

Frequencies of BCL2 and BCL6 translocations in representative Chinese follicular lymphoma patients: morphologic, immunohistochemical, and FISH analyses.

Pan Y, Meng B, Sun B, Guan B, Liang Y, Wang H, Hao X, Fu K.

Diagn Mol Pathol. 2012 Dec;21(4):234-40. doi: 10.1097/PDM.0b013e3182585c3c.

PMID:
22968395
3.

Bcl2-negative follicular lymphomas frequently have Bcl6 translocation and/or Bcl6 or p53 expression.

Guo Y, Karube K, Kawano R, Suzumiya J, Takeshita M, Kikuchi M, Huang GS, Li Q, Ohshima K.

Pathol Int. 2007 Mar;57(3):148-52.

PMID:
17295647
4.

BCL6-translocations affect the phenotype of follicular lymphomas only in the absence of t(14;18)IgH/BCL2.

Gollub W, Stassek B, Huckhagel T, Bernd HW, Krokowski M, Merz H, Feller AC, Thorns C.

Anticancer Res. 2009 Nov;29(11):4649-55.

5.

Follicular lymphomas with plasmacytic differentiation include two subtypes.

Gradowski JF, Jaffe ES, Warnke RA, Pittaluga S, Surti U, Gole LA, Swerdlow SH.

Mod Pathol. 2010 Jan;23(1):71-9. doi: 10.1038/modpathol.2009.146. Epub 2009 Oct 16.

6.

Lymphoid follicle colonization by Bcl-2(bright+)CD10(+) B-cells ("follicular lymphoma in situ") at nodal and extranodal sites can be a manifestation of follicular homing of lymphoma.

Lee JC, Hoehn D, Schecter J, Murty VV, Mansukhani MM, Alobeid B, Bhagat G.

Hum Pathol. 2013 Jul;44(7):1328-40. doi: 10.1016/j.humpath.2012.10.022. Epub 2013 Jan 28.

PMID:
23363648
8.
9.

Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases.

Mollejo M, Rodríguez-Pinilla MS, Montes-Moreno S, Algara P, Dogan A, Cigudosa JC, Juarez R, Flores T, Forteza J, Arribas A, Piris MA.

Am J Surg Pathol. 2009 May;33(5):730-8. doi: 10.1097/PAS.0b013e318193fcef.

PMID:
19194277
10.

Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray.

Zha H, Raffeld M, Charboneau L, Pittaluga S, Kwak LW, Petricoin E 3rd, Liotta LA, Jaffe ES.

Lab Invest. 2004 Feb;84(2):235-44.

11.

BCL6 gene amplification/3q27 gain is associated with unique clinicopathological characteristics among follicular lymphoma without BCL2 gene translocation.

Karube K, Ying G, Tagawa H, Niino D, Aoki R, Kimura Y, Hashikawa K, Suefuji N, Sugita Y, Nomura Y, Shimizu K, Yoshida S, Seto M, Ohshima K.

Mod Pathol. 2008 Aug;21(8):973-8. doi: 10.1038/modpathol.2008.75. Epub 2008 May 23.

12.

Oral follicular lymphomas. A short report of 8 cases with assessment of the IGH/BCL2 gene fusion with fluorescence in situ hybridization.

Argyris PP, Dolan M, Piperi E, Tosios KI, Pambuccian SE, Koutlas IG.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Sep;116(3):343-7. doi: 10.1016/j.oooo.2013.06.014.

PMID:
23953419
13.

The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-"negative" grade 1/2 follicular lymphomas.

Adam P, Baumann R, Schmidt J, Bettio S, Weisel K, Bonzheim I, Fend F, Quintanilla-Martínez L.

Hum Pathol. 2013 Sep;44(9):1817-26. doi: 10.1016/j.humpath.2013.02.004. Epub 2013 May 2.

PMID:
23642737
14.

Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3.

Borovecki A, Korać P, Nola M, Ivanković D, Jaksić B, Dominis M.

Croat Med J. 2008 Oct;49(5):625-35.

15.

Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.

de Leval L, Harris NL, Longtine J, Ferry JA, Duncan LM.

Am J Surg Pathol. 2001 Jun;25(6):732-41.

PMID:
11395550
16.

Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component.

Katzenberger T, Ott G, Klein T, Kalla J, Müller-Hermelink HK, Ott MM.

Am J Pathol. 2004 Aug;165(2):481-90.

17.

Interphase fluorescence in situ hybridization is more sensitive than BIOMED-2 polymerase chain reaction protocol in detecting IGH-BCL2 rearrangement in both fixed and frozen lymph node with follicular lymphoma.

Belaud-Rotureau MA, Parrens M, Carrere N, Turmo M, Ferrer J, de Mascarel A, Dubus P, Merlio JP.

Hum Pathol. 2007 Feb;38(2):365-72. Epub 2006 Nov 28.

PMID:
17134735
18.

Analysis of follicular lymphoma by dual-color fluorescence in situ hybridization.

Lee D, Seo J, Oh Y, Kim J, Ko Y.

Virchows Arch. 2008 Jan;452(1):75-81. Epub 2007 Nov 27.

PMID:
18040714
19.

Utility of immunohistochemistry with an antibody against MYC at the initial diagnosis of follicular lymphoma, grade 3A, for predicting a more aggressive clinical course: a case report and review of the literature.

Ichikawa K, Aritaka N, Ogura K, Hosone M, Ota Y, Sato E, Komatsu N, Hirano T.

Int J Clin Exp Pathol. 2015 Jun 1;8(6):7559-64. eCollection 2015. Review.

20.

Molecular-cytogenetic characterization of non-Hodgkin's lymphoma with double and cryptic translocations of the immunoglobulin heavy chain gene.

Kanda-Akano Y, Nomura K, Fujita Y, Horiike S, Nishida K, Nagai M, Miura I, Nakamura S, Seto M, Iida S, Ueda R, Taniwaki M.

Leuk Lymphoma. 2004 Aug;45(8):1559-67.

PMID:
15370207

Supplemental Content

Support Center